ReiThera

ReiThera Srl is a CDMO specialized in scalable process development and GMP manufacturing of viral vectors for gene therapies, vaccines, and advanced medicinal products. Based in Rome, Italy, the company operates a state-of-the-art facility equipped with bioreactors (2L–2000L), fixed-bed systems, fill/finish suites, and advanced quality control labs. ReiThera offers end-to-end support from lab-scale development to clinical and commercial-grade production. Its viral vector expertise includes AAV, MVA, LV, and HSV. Key platforms include: the Vaccinia lineage platform featuring MVA vectors with validated GMP processes and analytics; the proprietary GRAd platform for adenoviral vectors with rapid GMP transfer and scale-up; and the ReicellAVV cell line for efficient AAV vector production. ReiThera ensures flexible, high-quality production capabilities tailored to the needs of gene therapy and vaccine developers, supporting seamless clinical translation and commercialization of innovative biotherapeutics.